Nutcracker Therapeutics and Elegen see their mission as delivering scalable and low-cost RNA manufacturing for individualized therapies.

Life science researchers have developed tools that scan millions of papers weekly for signs of fraud, but detection remains challenging.

A novel optogenetic screening platform enables a high-throughput screen and identified several integrated stress response-potentiating compounds.